HYDRA: Possible determinants of unsatisfactory hypertension control in German primary care patients

Blood Pressure

Volumn 13, Issue 2, 2004, Pages 80-88

  Steckelings, Ulrike Muscha ^a   Stoppelhaar, Martina ^b   Sharma, Arya M ^c   Wittchen, Hans Ulrich ^d   Krause, Petra ^d   Küpper, Beate ^d   Kirch, Wilhelm ^d   Pittrow, David ^d   Ritz, Eberhard ^e   Göke, Burkhard ^f   Lehnert, Hendrik ^g   Tschöpe, Diethelm ^h   Höfler, Michael ⁱ   Pfister, Hildegard ⁱ   Unger, Thomas ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b Division Henning   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g OTTO VON GUERICKE UNIVERSITY   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Control rate; Epidemiology; Germany; Hypertension; Primary care

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EDUCATION PROGRAM; FEMALE; GERMANY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT EDUCATION; PRIMARY HEALTH CARE;

EID: 2342555691     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050310030982     Document Type: Article

References (25)

1. WHO/ISH Hypertension Guidelines Subcommittee. 1999-WHO-ISH guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
2. The seventh report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289: 2560-71.
3. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 45,000 people 45 prospective cohorts. Lancet 1995; 346: 1647-53.
4. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1993; 4: 265-71.
5. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747-52.
6. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997; 349: 454-7.
7. Coca A. Actual blood pressure control: are we doing things right. J Hypertens 1998; 16 Suppl 1: S45-51.
8. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-86.
9. Lloyd-Jones DM, Evans JC, Larson MG, Levy D. Treatment and control of hypertension in the community: a prospective analysis. Hypertension 2002; 40: 640-6.
10. Gasse C, Hense HW, Stieber J, Doring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens 2001; 15: 27-36.
11. Burt VL, Cutler JA, Higgins M, et al.. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26: 60-9.
12. HYDRA Study Group. Die HYDRA-Studie: Bundesweite Studie "Hypertension and Diabetes Screening and Awareness". Fortschritte der Medizin 2003; 121(S1): S1-44.
13. Sharma AM, Wittchen H-U, Kirch W, et al. for the HYDRA Study Group: High prevalence and poor control of hypertension in primary care: cross sectional study. J Hypertens 2004; 22: 1-9.
14. National Institute of Mental Health. 028 CGI clinical global impressions. In: Guy W, ed. ECD-EU assessment for psychopharmacology. Revised edition. Rockville, Maryland: National Institute of Mental Health, 1976: 217-22.
15. Tsai P-S. White coat hypertension: understanding the concept and examining the significance. J Clin Nurs 2002; 11: 715-22.
16. Alexander M, Tekawa I, Hunkeler E, et al.. Evaluating hypertension control in a managed care setting. Arch Intern Med 1999; 159: 2673-7.
17. Berlowitz DR, Ash AS, Hickey EC, et al.. Inadequate management of blood-pressure in a hypertensive population. New Engl J Med 1998; 339: 1957-63.
18. Dickerson JEC, Brown MJ. Influence of age on general practitioners' definition and treatment of hypertension. BMJ 1995; 310: 574.
19. The Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1984; 144: 1045-7.
20. Izzo JL, Jr, Levy D, Black HR. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-4.
21. Phillips LS, Branch WT, Jr, Cook CB, et al.. Clinical inertia. Ann Intern Med. 2001; 135: 825-34.
22. Hyman DJ, Valory NP. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med 2000; 160: 2281-6.
23. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
24. Costa FV. Compliance with antihypertensive treatment. Clin Exp Hypertens 1996; 18: 463-72.
25. Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J 1996; 17 Suppl A: S16-20.